Should We Trust "Big Data" or "Meta-Data" to Guide Treatment for Patients with Resectable Esophageal Cancer?
J Am Coll Surg
.
2017 May;224(5):996-997.
doi: 10.1016/j.jamcollsurg.2017.01.046.
Authors
Guang H Yim
1
,
Sandro Pasquali
2
,
Ravinder Vohra
3
,
Ewen Griffiths
4
Affiliations
1
Bristol, UK.
2
Padua, Italy.
3
Nottingham, UK.
4
Birmingham, UK.
PMID:
28449935
DOI:
10.1016/j.jamcollsurg.2017.01.046
No abstract available
Publication types
Letter
Comment
MeSH terms
Adenocarcinoma*
Chemoradiotherapy
Esophageal Neoplasms*
Esophagogastric Junction
Humans
Neoadjuvant Therapy